AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

The mega investment includes 2 billion dollars of new investment which is expected to create more than a thousand new, ...